Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran monotherapy in fibromyalgia
NCT00314249Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Forest Laboratories. Started Apr 2006; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00314249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314249.